DOI QR코드

DOI QR Code

The Correlation between SCORAD Index and Serum Total IgE or Eosinophil Count in Individual Patients of Atopic Dermatitis

아토피피부염 환자에서 중증도 변화에 따른 SCORAD index와 혈청 총 IgE 및 호산구 수의 상관관계

  • Kwak, Jae-Young (Department of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, Kyung Hee University Hospital at Gangdong) ;
  • Kim, Min-Hee (Department of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, Kyung Hee University Hospital at Gangdong) ;
  • Kang, Min-Seo (Department of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, Kyung Hee University Hospital at Gangdong) ;
  • Choi, In-Hwa (Department of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, Kyung Hee University Hospital at Gangdong)
  • 곽재영 (강동경희대학교병원 한방안이비인후피부과) ;
  • 김민희 (강동경희대학교병원 한방안이비인후피부과) ;
  • 강민서 (강동경희대학교병원 한방안이비인후피부과) ;
  • 최인화 (강동경희대학교병원 한방안이비인후피부과)
  • Received : 2018.01.13
  • Accepted : 2018.02.12
  • Published : 2018.02.25

Abstract

Objectives : This study was aimed to evaluate the correlation between changes in disease severity and serum total IgE or eosinophil count in individual patients of atopic dermatitis depending on the change of severity. Methods : We performed a retrospective chart review of 8 cases of atopic dermatitis who underwent blood tests more than five times. Disease severity was assessed by objective SCORing of Atopic Dermatitis index (OSI). Blood tests include serum total IgE, eosinophil counts, aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN) and serum creatinine (SCr). In each subject, on the day that the blood test was performed, OSI was also assesed by a same physician. Correlation between OSI and total IgE or eosinophil count was analysed by nonparametric correlation analysis. Results : There was a statistically significant positive correlation between OSI and total IgE in three cases and a positive correlation between OSI and eosinophil count in two cases. In other three cases, there were no significant correlation. There were no cases that OSI correlated with total IgE and eosinophil count at the same time. In all cases, AST, ALT, BUN and SCr were stable. Conclusions : We suggest that total IgE and eosinophil count may reflect the severity of atopic dermatitis differently in individual patients. We also suggest that total IgE and eosinophil counts may be used as biomarkers to predict the severity of atopic dermatitis in some patients depending on the underlying pathology.

Keywords

References

  1. Williams H, Robertson C, Stewart A, Ait-Khaled N, Anabwani G, Anderson R, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. Journal of allergy and clinical immunology. 1999;103(1):125-38. https://doi.org/10.1016/S0091-6749(99)70536-1
  2. Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387(10023):1109-22. https://doi.org/10.1016/S0140-6736(15)00149-X
  3. Hanifin J, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol(Stockh)(suppl). 1980;92:44-7.
  4. Park GH, Park JH, Hwang YH, Seong MS, Kim SW. The correlation between the severity of atopic dermatitis classified by SCORing atopic dermatitis index and the laboratory tests. Allergy Asthma & Respiratory Disease. 2013;1(1):79-83. https://doi.org/10.4168/aard.2013.1.1.79
  5. Noh G, Lee K. Blood eosinophils and serum IgE as predictors for prognosis of interferongamma therapy in atopic dermatitis. Allergy. 1998;53(12):1202-7. https://doi.org/10.1111/j.1398-9995.1998.tb03842.x
  6. Kim MN, Shin BJ, Tak WJ, Ro BI, Park AJ. Eosinophil counts in peripheral blood, serum total IgE, eosinophil cationic protein, IL-4 and soluble E-selectin in atopic dermatitis. Korean Journal of Dermatology. 2002;40(11):1367-73.
  7. Lee JH. A Study on the Relationship of the Severity of Atopic Dermatitis, Serum IgE and IFN-gamma. Korean Journal of Dermatology. 2001;39(10):1067-71.
  8. Kiehl P, Falkenberg K, Vogelbruch M, Kapp A. Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining. British Journal of Dermatology. 2001;145(5):720-9. https://doi.org/10.1046/j.1365-2133.2001.04456.x
  9. Simon D, Braathen L, Simon HU. Eosinophils and atopic dermatitis. Allergy. 2004;59(6):561-70. https://doi.org/10.1111/j.1398-9995.2004.00476.x
  10. Kunz B, Oranje A, Labreze L, Stalder J-F, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10-9.
  11. Bieber T. Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine. Allergy. 2012;67(12):1475-82. https://doi.org/10.1111/all.12049
  12. Thijs JL, de Bruin-Weller MS, Hijnen D. Current and future biomarkers in atopic dermatitis. Immunology and Allergy Clinics. 2017;37(1):51-61. https://doi.org/10.1016/j.iac.2016.08.008
  13. Novak N, Bieber T. Allergic and nonallergic forms of atopic diseases. Journal of Allergy and Clinical Immunology. 2003;112(2):252-62. https://doi.org/10.1067/mai.2003.1595
  14. Clendenning WE, Clack WE, Ogawa M, Ishizaka K. Serum IgE studies in atopic dermatitis. Journal of Investigative Dermatology. 1973;61(4):233-6. https://doi.org/10.1111/1523-1747.ep12676481
  15. Kang DG, Park CW, Lee CH. The serum eosinophils and serum IgE in patients with atopic dermatitis. Korean Journal of Dermatology. 1992;30(1):51-6.
  16. Simon D, Simon HU, Akdis C, Wüthrich B. Epidemiology, clinical features, and immunology of the “intrinsic”(non‐IgE‐mediated) type of atopic dermatitis (constitutional dermatitis). Allergy. 2001;56(9):841-9. https://doi.org/10.1034/j.1398-9995.2001.00144.x
  17. Uehara M, Izukura R, Sawai T. Blood eosinophilia in atopic dermatitis. Clinical and experimental dermatology. 1990;15(4):264-6. https://doi.org/10.1111/j.1365-2230.1990.tb02086.x
  18. Park SY, Oh S, Kim EJ, Yoon SY, Park HS, Yoon H-S, et al. Utility of eosinophil cationic protein levels in the diagnosis of intrinsic atopic dermatitis. Acta dermato-venereologica. 2014;94(3):333-4. https://doi.org/10.2340/00015555-1715
  19. Kim HS, Kim JH, Seo YM, Chun YH, Yoon J-s, Kim HH, et al. Eosinophil-derived neurotoxin as a biomarker for disease severity and relapse in recalcitrant atopic dermatitis. Annals of Allergy, Asthma & Immunology. 2017;119(5):441-5. https://doi.org/10.1016/j.anai.2017.06.022
  20. Thijs JL, Nierkens S, Herath A, Bruijnzeel-Koomen C, Knol EF, Giovannone B, et al. A panel of biomarkers for disease severity in atopic dermatitis. Clinical & Experimental Allergy. 2015;45(3):698-701. https://doi.org/10.1111/cea.12486
  21. Thijs JL, Strickland I, Bruijnzeel-Koomen CA, Nierkens S, Giovannone B, Csomor E, et al. Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysis. Journal of Allergy and Clinical Immunology. 2017;140(3):730-7. https://doi.org/10.1016/j.jaci.2017.03.023